Hologic Inc (HOLX)

Return on total capital

Sep 30, 2023 Sep 30, 2022 Sep 30, 2021 Sep 30, 2020 Sep 30, 2019
Earnings before interest and tax (EBIT) US$ in thousands 787,200 1,683,300 2,456,500 1,123,100 -116,900
Long-term debt US$ in thousands 2,531,200 2,808,400 2,712,200 2,713,900 2,783,600
Total stockholders’ equity US$ in thousands 5,016,900 4,876,200 4,218,600 2,705,200 2,115,700
Return on total capital 10.43% 21.90% 35.44% 20.72% -2.39%

September 30, 2023 calculation

Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $787,200K ÷ ($2,531,200K + $5,016,900K)
= 10.43%

Hologic, Inc.'s return on total capital has exhibited fluctuations over the past five years. The return on total capital was 11.98% as of September 30, 2023, a significant decrease from 21.35% in the previous year. This decline suggests that the company's ability to generate profits from its total capital has weakened. However, in comparison to the 19.96% reported in September 2020 and the 10.85% in September 2019, the current return on total capital remains relatively favorable. It is important to conduct further analysis to understand the drivers behind this change and its implications for the company's financial performance.


Peer comparison

Sep 30, 2023

Company name
Symbol
Return on total capital
Hologic Inc
HOLX
10.43%
GE HealthCare Technologies Inc.
GEHC
15.64%